Skip to content

A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bordetella pertussis using controlled human infection (KIM-study)

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508416-35-00
Acronym
PaNaMa ID: 114794
Enrollment
99
Registered
2024-06-04
Start date
2024-10-16
Completion date
Unknown
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis or 'whooping cough'

Brief summary

Bp colonisation rate in Tdap-IPV and Td-IPV vaccination groups, with Bp colonisation defined as any positive Bp culture from nasal wash samples at any time point between Day 3 and Day 28 after challenge, Bp colonisation rate in Tdap-IPV vaccination groups, with Bp colonisation defined as any positive Bp culture from nasal wash samples at any time point between Day 3 and Day 28 after challenge

Interventions

DRUGAzitromycine 500 mg Teva
DRUGREVAXIS Suspensie voor injectie in voorgevulde spuit. Difterie
DRUGtetanus en poliomyelitis (geïnactiveerd) vaccin
DRUGgeadsorbeerd
DRUGbeperkte hoeveelheid antigen(en).
DRUGin pre-filled syringe Diphtheria
DRUGTetanus
DRUGcomponent) and Poliomyelitis (inactivated) Vaccine (adsorbed
DRUGreduced antigen(s) content)

Sponsors

Stichting Radboud University Medical Center
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Bp colonisation rate in Tdap-IPV and Td-IPV vaccination groups, with Bp colonisation defined as any positive Bp culture from nasal wash samples at any time point between Day 3 and Day 28 after challenge, Bp colonisation rate in Tdap-IPV vaccination groups, with Bp colonisation defined as any positive Bp culture from nasal wash samples at any time point between Day 3 and Day 28 after challenge

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026